Overview

Mirabegron for Treatment of Erectile Dysfunction in Patients With LUTS Secondry to BPH: A Randomized Study

Status:
Unknown status
Trial end date:
2020-01-01
Target enrollment:
Participant gender:
Summary
To study the impact of mirabegron, a B3-adrenoceptor agonist, in the treatment of ED in patients with LUTS secondary to BPH and concomitant ED.
Phase:
Phase 2
Details
Lead Sponsor:
Mansoura University
Treatments:
Mirabegron
Tamsulosin